Crohn's Disease - Epidemiology Forecast to 2029

2020-09-15
Price :
Published : Sep-2020
No. of Pages : 47
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Crohn's Disease: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Forecast Assumptions and Methods: Diagnosed Incident Cases of CD
3.4.4 Forecast Assumptions and Methods: Diagnosed Prevalent Cases of CD
3.4.5 Forecast Assumptions and Methods: Diagnosed Prevalent Cases of CD by Severity and Diagnosed Prevalent Cases of Fistulizing CD by Severity
3.5 Epidemiological Forecast for CD (2019-2029)
3.5.1 Diagnosed Incident Cases of CD
3.5.2 Age-Specific Diagnosed Incident Cases of CD
3.5.3 Sex-Specific Diagnosed Incident Cases of CD
3.5.4 Diagnosed Prevalent Cases of CD
3.5.5 Age-Specific Diagnosed Prevalent Cases of CD
3.5.6 Sex-Specific Diagnosed Prevalent Cases of CD
3.5.7 Diagnosed Prevalent Cases of CD by Severity
3.5.8 Diagnosed Prevalent Cases of Fistulizing CD by Severity
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Coronavirus Disease 2019 (COVID-19) Impact
3.6.3 Limitations of the Analysis
3.6.4 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 Primary Research - Prescriber Survey
4.3 About the Authors
4.3.1 Epidemiologist
4.3.2 Reviewers
4.3.3 Global Director of Therapy Analysis and Epidemiology
4.3.4 Global Head and EVP of Healthcare Operations and Strategy
4.4 About GlobalData
4.5 Contact Us
4.6 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for CD
Table 4: High-Prescribing Physicians (non-KOLs) Surveyed for Severity of CD, By Country
Table 5: High-Prescribing Physicians (non-KOLs) Surveyed for Severity of Fistulizing CD, By Country

List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of CD, Both Sexes, N, All Ages, 2019 and 2029
Figure 2: 8MM, Diagnosed Prevalent Cases of CD, Both Sexes, N, All Ages, 2019 and 2029
Figure 3: 8MM, Diagnosed Incidence of CD, Men and Women, Cases per 100,000 Population, All Ages, 2019
Figure 4: 8MM, Diagnosed Prevalence of CD, Men and Women, %, All Ages, 2019
Figure 5: 8MM, Sources Used and Not Used to Forecast the Diagnosed Incident Cases of CD
Figure 6: 8MM, Sources Used and Not Used to Forecast the Diagnosed Prevalent Cases of CD
Figure 7: 8MM, Diagnosed Incident Cases of CD, N, Both Sexes, All Ages, 2019
Figure 8: 8MM, Diagnosed Incident Cases of CD by Age, N, Both Sexes, 2019
Figure 9: 8MM, Diagnosed Incident Cases of CD by Sex, N, All Ages, 2019
Figure 10: 8MM, Diagnosed Prevalent Cases of CD, N, Both Sexes, All Ages, 2019
Figure 11: 8MM, Diagnosed Prevalent Cases of CD by Age, N, Both Sexes, 2019
Figure 12: 8MM, Diagnosed Prevalent Cases of CD by Sex, N, All Ages, 2019
Figure 13: 8MM, Diagnosed Prevalent Cases of CD by Severity, N, All Ages, 2019
Figure 14: 8MM, Diagnosed Prevalent Cases of Fistulizing CD by Severity, N, All Ages, 2019
Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData